GenomOncology said it will integrate Pacific Biosciences’ HiFi whole-genome sequencing secondary analysis pipeline into its Pathology Workbench reporting platform. The company’s stated goal is to standardize the bridge from instrument output—aligned reads and variant calls—to clinician-ready reports with quality control, variant interpretation, and evidence curation. The move targets an operational bottleneck for laboratories adopting long-read WGS, where translating research-use outputs into reportable clinical context has been a recurring friction point. By combining research-use PacBio secondary analysis with Workbench tertiary workflows, GenomOncology aims to make reporting more scalable across tumor types and myeloid-focused panels.